Why Never we see a lot more head-to-head trials of competitor medicine? The answer is pretty very simple, Truthfully: risk administration. For medicine that happen to be on patent, such as the GLP-1s, conducting a trial with no obtain-in on the pharmaceutical corporation is simply too costly — we will not run a demo Until a person delivers the dr